Reuters: Health
Novartis on Friday announced positive study results for its prospective multiple sclerosis drug ofatumumab that the Swiss drugmaker hopes will pose a stiff challenge to Roche's medicine Ocrevus in a highly competitive market.
Novartis begins hunt for piece of Roche's growing MS empire
Novartis begins hunt for piece of Roche's growing MS empire
Reuters: Health
Novartis on Friday announced positive study results for its prospective multiple sclerosis drug ofatumumab that the Swiss drugmaker hopes will pose a stiff challenge to Roche's medicine Ocrevus in a highly competitive market.
Reuters: Health
Novartis on Friday announced positive study results for its prospective multiple sclerosis drug ofatumumab that the Swiss drugmaker hopes will pose a stiff challenge to Roche's medicine Ocrevus in a highly competitive market.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment